logo

For the Inventor, By the Inventor

Lexington, MA, United States of America

Susan Laurene Acton

This inventor holds 33 USPTO granted patents and 3 published patent applications, primarily in Cardiovascular Research. Top assignees: Millennium Pharmaceuticals Limited, Massachusetts Institute of Technology, The University of Texas System. Active years: 1999-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susan Laurene Acton. Retrieved from https://idiyas.com/inventor/susan-laurene-acton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 

% Patents Active = 84.8

Average Co-Inventor Count = 1.4

ph-index = 8

Forward Citations = 151(Granted Patents)


Location History:

  • Jamaica Plain, MA (US) (1999 - 2001)
  • Somerville, MA (US) (2002 - 2006)
  • Lexington, MA (US) (1999 - 2009)

Company Filing History:

goldMedal28 out of 854 
 
Millennium Pharmaceuticals Limited
 patents
silverMedal4 out of 8,586 
 
Massachusetts Institute of Technology
 patents
bronzeMedal1 out of 5,638 
 
The University of Texas System
 patents
4. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2009

Loading Chart...
Areas of Expertise:
Angiotensin Converting Enzyme
Cardiovascular Proteins
CSAPK Antibodies
Protein Kinase
Lipid Metabolism
Therapeutic Methods
Diagnostic Assays
Scavenger Receptors
Nucleic Acids
Metabolic Pathways
33 patents (USPTO):Explore Patents
1. 7482171 - Angiotensin converting enzyme homolog and uses therefor (2009-01-27),
2. 7268218 - Cardiovascular system associated protein kinase 3 (CSAPK-3) antibodies (2007-09-11),
3. 7078511 - Class BI and CI scavenger receptors (2006-07-18),
4. 7045532 - ACE-2 modulating compounds and methods of use thereof (2006-05-16),
5. 7001753 - 59079 and 12599, protein kinase family members and uses therefor (2006-02-21),
6. 6989363 - Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor (2006-01-24),
7. 6884771 - Angiotensin converting enzyme homolog and uses therefor (2005-04-26),
8. 6740737 - Cardiovascular system associated protein kinase 2 (CSAPK-2) antibodies (2004-05-25),
9. 6632830 - ACE-2 inhibiting compounds and methods of use thereof (2003-10-14),
10. 6610497 - Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor (2003-08-26),
11. 6436685 - CSAPTP protein molecules and uses therefor (2002-08-20),
12. 6429289 - Class BI and CI scavenger receptors (2002-08-06),
13. 6350859 - Class BI and CI scavenger receptors (2002-02-26),
14. 6268135 - Phospholipase molecule and uses therefor (2001-07-31),
15. 6258582 - CSAPTP nucleic acid molecules and uses therefor (2001-07-10),

Title: Innovations and Contributions of Susan Laurene Acton

Introduction

Susan Laurene Acton, based in Lexington, MA, is a prominent inventor with an impressive portfolio of 33 patents. Her innovative work primarily focuses on advancements in biotechnology and medical applications, showcasing the impact of her contributions on therapeutic strategies and diagnostic methods.

Latest Patents

Among her notable inventions is the patent titled "Angiotensin converting enzyme homolog and uses therefor." This invention pertains to the discovery of novel genes encoding an angiotensin converting enzyme known as Angiotensin Converting Enzyme-2 (ACE-2). The therapeutic applications of this invention play a crucial role in treating blood pressure-related disorders and various allergic conditions, supplemented by methods for screening compounds that may prevent or treat these conditions. Another significant patent granted to Susan is for "Cardiovascular system associated protein kinase 3 (CSAPK-3) antibodies." This invention includes isolated nucleic acid molecules that encode unique protein kinases, alongside diagnostic and therapeutic applications, providing a comprehensive approach to utilizing CSAPK proteins in medical science.

Career Highlights

Susan has been associated with esteemed organizations such as Millennium Pharmaceuticals Limited and the Massachusetts Institute of Technology. Her roles in these institutions have solidified her reputation as a leading figure in the realm of biotechnology, reflecting her dedication to research and development in innovative health solutions.

Collaborations

Throughout her career, Susan has collaborated with notable individuals, including Keith Earl Robison and Monty Krieger. These partnerships have fostered an environment of shared knowledge and exploration, enhancing the scope and reach of her inventions and innovations.

Conclusion

Susan Laurene Acton's contributions to the field of biotechnology through her numerous patents and collaborations highlight her as a vital inventor in the industry. Her commitment to advancing medical science continues to inspire new therapeutic methods and innovations that benefit countless individuals worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…